| # | Drug | Count |
|---|---|---|
| 0 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 4 |
| 1 | INFLIXIMAB | 3 |
| 2 | PREDNISONE | 3 |
| 3 | IBUPFROFEN | 2 |
| 4 | IBUPROFEN | 2 |
| 5 | IBUPROFEN 200 MG | 2 |
| 6 | IBUPROFEN 200MG | 2 |
| 7 | IBUPROFEN CAPSULE | 2 |
| 8 | IBUPROFEN CAPSULES 200 MG | 2 |
| 9 | IBUPROFEN ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALUMINUM CHLORIDE | 1 | 0.0066 |
| 1 | VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR | 1 | 0.0013 |
| 2 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 4 | 0.0003 |
| 3 | TOBRAMYCIN SOLUTION | 2 | 0.0002 |
| 4 | TOBRAMYCIN SULFATE | 2 | 0.0002 |
| 5 | AZTREONAM | 1 | 0.0001 |
| 6 | LUMACAFTOR AND IVACAFTOR | 1 | 0.0001 |
| 7 | TOBRAMYCIN | 2 | 0.0001 |
| 8 | POSACONAZOLE | 1 | 0.0001 |
| 9 | PROPRANOLOL HYDROCHLORIDE | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 2 | 0.0001 |
| 1 | Aminoglycoside Antibacterial [EPC] | 2 | 0.0000 |
| 2 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 5 | Corticosteroid [EPC] | 4 | 0.0000 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 3 | 0.0000 |
| 7 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 | 0.0000 |